Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL14744879

CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc(N2CCNCC2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KHK P50053 2/20 0.39
EZH2 Q15910 3/20 0.39
ALDH1A1 P00352 2/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
BRD4 O60885 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
CYP2J2 P51589 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
P2RY14 Q15391 1/20 0.38
USP2 O75604 1/20 0.38
CTSL P07711 3/20 0.37
CTSB P07858 2/20 0.37
CTSS P25774 2/20 0.37
CTSK P43235 1/20 0.37
ACVR1 Q04771 2/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14745182 0.95 KHK (0.42) KHKEZH2ALDH1A1TSHRHSD17B10
Trifluoroacetic Acid SCHEMBL14745941 0.86 LMNA (0.46) ALDH1A1TSHRHSD17B10LMNAKDM4E
SCHEMBL14745092 0.86 PARP1 (0.43) ALDH1A1TSHRHSD17B10LMNAHPGD
SCHEMBL14741099 0.86 PARP1 (0.41) ALDH1A1HSD17B10LMNAKDM4EHPGD
SCHEMBL14744882 0.85 EZH2 (0.38) KHKEZH2P2RY14ACVR1METAP2
SCHEMBL14741042 0.85 DHODH (0.44) ALDH1A1LMNAHTT
SCHEMBL14740829 0.84 SLC16A3 (0.45) ALDH1A1HSD17B10LMNAKDM4EHPGD
Trifluoroacetic Acid SCHEMBL14745223 0.83 DYRK1A (0.42) HRH4
Trifluoroacetic Acid SCHEMBL14745308 0.82 KCNH2 (0.34) ALDH1A1TSHRHSD17B10HPGDUSP2
SCHEMBL14745094 0.82 PDE3B (0.40) ALDH1A1HSD17B10KDM4EHPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016039936-A2 MONOCYCLIC SUBSTITUTED 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS PTC THERAPEUTICS, INC. (US) 2016-03-17 WO claimed
US-20150080362-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS, INC. (US) 2015-03-19 US claimed
EP-2750505-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC Therapeutics, Inc. (US) 2014-07-09 EP disclosed
WO-2013033240-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS, INC. (US) 2013-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150080362-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE MRPL21, SLC11A2, CLPP KHK 2681/4885EZH2 4621/4885ALDH1A1 3792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.